Quality-of-life outcomes in patients who underwent subcutaneous immunotherapy and sublingual immunotherapy in a real-world clinical setting.
CONCLUSION: Although improvements in QOL were noted in both groups, changes in overall scores and the majority of domains only achieved statistical significance in the SCIT group. A small study population and difficulties adhering to immunotherapy dosing schedules in the SLIT group may be contributing factors.
PMID: 28859707 [PubMed - in process]
Source: American Journal of Rhinology and Allergy - Category: ENT & OMF Authors: Schwanke T, Carragee E, Bremberg M, Reisacher WR Tags: Am J Rhinol Allergy Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | ENT & OMF | Hay Fever | Immunotherapy | Sleep Disorders | Sleep Medicine | Statistics | Study